FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Clinical trial NCT06303505 · RECRUITING
Trial details
- NCT number
- NCT06303505
- Sponsor
- Tubulis GmbH
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2027-12-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.